Haemonetics Corporation

NYSE:HAE

Sector

🏥 Health Care

Industries

🏥 Hospitals & Clinics

🩺 Medical Instruments

💻 Software & Operating Systems

Location

United States

Market Cap

USD 2.60 B

Share Price

USD 53.98

Avg Daily Volume

771,520

Change (1 day)

-0.86%

Change (1 year)

-28.42%

Change (YTD)

-30.87%

Haemonetics Corporation EBIT Margin for the Trailing 12 Months (TTM) ending June 28, 2025: 17.18%

Haemonetics Corporation EBIT Margin is 17.18% for the Trailing 12 Months (TTM) ending June 28, 2025, a 38.94% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Haemonetics Corporation EBIT Margin for the Trailing 12 Months (TTM) ending June 29, 2024 was 12.37%, a -15.77% change year over year.
Haemonetics Corporation EBIT Margin for the Trailing 12 Months (TTM) ending July 01, 2023 was 14.68%, a 36.92% change year over year.
Haemonetics Corporation EBIT Margin for the Trailing 12 Months (TTM) ending July 02, 2022 was 10.72%, a 21.99% change year over year.
Haemonetics Corporation EBIT Margin for the Trailing 12 Months (TTM) ending July 03, 2021 was 8.79%, a -35.24% change year over year.